INVESTOR PRESENTATION
Q2 2020
ENPRO INDUSTRIES INVESTOR PRESENTATION Q2 2020 FORWARD-LOOKING - - PowerPoint PPT Presentation
ENPRO INDUSTRIES INVESTOR PRESENTATION Q2 2020 FORWARD-LOOKING STATEMENTS Statements made in the course of this presentation that express a belief, expectation or intention, as well as those that are not historical fact, are forward-looking
INVESTOR PRESENTATION
Q2 2020
Statements made in the course of this presentation that express a belief, expectation or intention, as well as those that are not historical fact, are forward-looking statements under the Private Securities Litigation Reform Act of 1995. They involve a number of risks and uncertainties that may cause actual events and results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to: impacts from the COVID-19 pandemic and governmental responses to limit the further spread of COVID-19, including impacts on the company’s operations, and the operations and businesses of its customers and vendors, including whether the company’s operations and those of its customers and vendors will continue to be treated as “essential” operations under government orders restricting business activities or, even if so treat ed, whether site-specific health and safety concerns might otherwise require certain of the company’s operations to be halted for some period of time; uncertainty with respect to the duration and severity of these impacts from the COVID-19 pandemic, including impacts on the general economy; other economic conditions in the markets served by EnPro’s businesses, some of which are cyclical and experience periodic downturns; prices and availability of its raw materials; the impact of fluctuations in relevant foreign currency exchange rates; unanticipated delays or problems in introducing new products; announcements by competitors of new products, services or technological innovations; changes in pricing policies or the pricing policies of competitors; the impact of the acquisition of LeanTeq on its existing customer relationships; and the amount of any payments required to satisfy contingent liabilities related to discontinued operations of its predecessors, including liabilities for certain products, environmental matters, employee benefit obligations and other
uncertainties in more detail. EnPro does not undertake to update any forward-looking statements made in the course of this presentation to reflect any change in management's expectations or any change in the assumptions or circumstances on which such statements are based. We own a number of direct and indirect subsidiaries and, from time to time, we may refer collectively to EnPro and one or more of our subsidiaries as “we” or to the businesses, assets, debts or affairs of EnPro or a subsidiary as “ours.” These and similar references are for convenience only and should not be construed to change the fact that EnPro and each subsidiary is an independent entity with separate management, operations, obligations and affairs. This presentation also contains certain non-GAAP financial measures (*) as defined by the Securities and Exchange Commission. A reconciliation of non-GAAP measures to the most directly comparable GAAP equivalents is included as an appendix to this presentation.
2
4
Leading Provider of Highly-Engineered Solutions for Mission Critical Applications with #1-3 Market Positions COMPANY OVERVIEW (NYSE: NPO)
Headquarters Charlotte, NC Manufacturing Facilities 27 primary Global Employees 5,000+ Customers 50,000+
FINANCIAL OVERVIEW
Market-Cap1 $1.1B LTM Revenue2 $1.2B LTM Adj. EBITDA (Margin)2,3 $176M (14.8%) 2019 Aftermarket Rev. 58% Dividend Yield1 1.9%
1 As of 6/8/20; 2 LTM as of 3/31/20; 3 Refer to appendix for Non-GAAP reconciliation; Note: Excludes Fairbanks Morse, w hich is now reported as a discontinued operation
5
SALES BY SEGMENT SALES BY GEOGRAPHY SALES BY CHANNEL 75% 25%
SEALING PRODUCTS ENGINEERED PRODUCTS
62% 25% 10%3%
NORTH AMERICA EUROPE ASIA ROW
58% 42%
AFTERMARKET OE
2019 REVENUE CONTRIBUTION
6
LTM 3/31/20 REVENUE $903M LTM 3/31/20 ADJ. EBITDA MARGIN 19%
SEALING PRODUCTS
KEY PRODUCT OFFERINGS:
Services
ENGINEERED PRODUCTS
LTM 3/31/20 REVENUE $287M LTM 3/31/20 ADJ. EBITDA MARGIN 15%
KEY PRODUCT OFFERINGS:
REVENUE COMPOSITION (2019) REVENUE COMPOSITION (2019) 38% STEMCO 33% GARLOCK 29% TECHNETICS 65% GGB 35% CPI
Leadership in high-value niche markets with established, premium brands Supporting mission-critical applications in highly demanding and extreme operating environments Low-cost relative to applications served; value-based pricing leverage Applying manufacturing know-how and trade secrets; significant application and technical expertise Embedded with our customers; substantial switching costs and barriers to entry
SEALING PRODUCTS
bearings
sealing
ENGINEERED PRODUCTS
automotive applications
applications
compressors
7
Market SEMICONDUCTOR PHARMACEUTICAL Macroeconomic Growth Drivers
and memory:
greater life expectancy
foods and medicines
EnPro’s Focus
maintenance cost
process becomes more critical as process yields are impacted more severely by foreign particles
tubing and single-use products
greater regulation and overall demand growth for pharmaceuticals
8
9
58% Aftermarket / 42% OEM
2019 Sales
WE ARE A PURPOSE-DRIVEN COMPANY WITH STRONG VALUES, A FORWARD-THINKING OPERATING PHILOSOPHY, AND A WAY OF WORKING THAT DRIVES BEST-IN- CLASS VALUE CREATION OVER THE LONG TERM.
HIGHLY ENGINEERED PRODUCTS AND SERVICES THAT PROVIDE DIFFERENTIATED PERFORMANCE DERIVED FROM MATERIALS SCIENCE EXPERTISE, MANUFACTURING KNOW- HOW, AND TRADE SECRETS DUAL-BOTTOM LINE CULTURE ENABLING HUMAN DEVELOPMENT THROUGH THE WAY WE WORK COMMITMENT TO SOCIALLY AND ENVIRONMENTALLY RESPONSIBLE PRACTICES
10
We Have Taken Numerous Actions to Maintain our Business Operations and Ensure the Safety of Our Employees
12
Protecting Our People Protecting our Business Protecting our Community
where feasible
working remotely and virtual meetings
cleaning and disinfecting protocols
facilities
procedures such as temperature scanning, use of masks, and social distancing
for updates on the actions we are taking, status of all of facilities, and FAQ’s
initiatives
ensure efficient accounts receivable processing with our customers
(N95) masks to doctors and hospitals in the United States and Europe
suppliers to source difficult to find materials like infrared thermometers and masks
medical supplies for themselves and their families’ immediate need within COVID-19 afflicted areas
13
Our cross-functional COVID-19 Response & Support Team, made up of our global executive leadership team, is working around the clock to manage our business continuity plans and coordinated response
THE HEALTH AND SAFETY OF OUR EMPLOYEES, COMMUNITIES, CUSTOMERS, AND SUPPLIERS IS OUR NUMBER ONE PRIORITY
Phase 1 Health and Safety Phase 2 Business Stability and Progression Phase 3 Process Improvement Phase 4 Post-pandemic Period
Support Team
playbook’, a standardized approach for COVID-19 pandemic preparedness and response
line with recommendations from global and local authorities
work options
including temperature screenings, additional PPE, physical plexiglass workspace barriers, and enhanced visual management to support social distancing
scenarios
adverse conditions, resetting business to new demand levels, managing liquidity, and being responsive to customers
prevent the spread of COVID-19
changing demand levels
progression, and risk mitigation
− Processes − Procedures − New ways of working
to thrive in new environment
and work routines
Taking the Necessary Actions to Protect our People and Organization
Strong and Flexible Balance Sheet Positions Company to Confidently Weather Downturn and Capitalize on Further Opportunities
14
COMMENTARY
current authorization
receivables this year, free cash flow was $13.8 million in Q1 2020 compared to negative $4.5 million in Q1 2019
applicable reinvestment requirements related to the Fairbanks Morse divestiture
DEBT MATURITY SCHEDULE NET LEVERAGE
$150M $350M Undrawn $400M
2020 2021 2022 2023 2024 2025 2026
Term Loan A Senior Unsecured Notes Revolver
Reported March 31, 2020 ($M) Credit Facility $0 Senior Notes(1) $345 Term Loan $149 Capital Lease Obligations $1 A Debt Components $495 B Cash and Equivalents $391 C = (A – B) Net Debt $104 D LTM March 31, 2020 Adjusted EBITDA* $176 E = (C / D) Leverage Ratio 0.6x
(1) Includes impact from unamortized debt issue costs * Non-GAAP measure; refer to appendix for reconciliation to GAAP Note: LTM March 31, 2020 Adjusted EBITDA includes three quarters of contribution from The Aseptic Group acquisition and tw o quarters contribution from LeanTeq acquisition
Well Prepared for the Near-T erm Challenges and Will Move Quickly to Address Additional Risks as they Present Themselves
15
SCENARIO ANALYSIS INSIGHTS:
needed, to adjust businesses to meet new demand levels and recover from economic slowdown
Q1 MARKET EXPOSURE:
TOTAL ENPRO SEALING PRODUCTS ENGINEERED PRODUCTS
32% 21% 17% 7% 6% 5% 5% 3% 3% 1%
MD/HD Truck General Industrial Semiconductors Oil & Gas Aerospace Food & Pharma Power Generation Petrochemical Metals & Mining Other
30% 29% 15% 14% 6% 3% 1% 1%
Automotive General Industrial Oil & Gas Petrochemical Power Generation Aerospace Food & Pharma Metals & Mining
24% 23% 13% 9% 7% 5% 5% 5% 4%3%1%
MD/HD Truck General Industrial Semiconductors Oil & Gas Automotive Aerospace Petrochemical Power Generation Food & Pharma Metals & Mining Other
17
Reshape our portfolio towards businesses with compelling margins, leading technology, and high cash flow return on investment in markets with favorable secular tailwinds Maintaina balanced approach to capital allocation Increase aftermarket exposure and recurring revenue opportunities Leverage the EnPro Operating System for continuous improvement to increase margins and cash flow return on investment
18
Increasing Profits
recurring revenue mix
inorganic investments Driving Inorganic Growth
existing high-growth markets Improving Capital Efficiency
margins and cash flow return on investment
shareholder returns Maintaining Market Leadership
secrets Driving Dual Bottom Line Culture
superior decision-making
LeanTeq Co., Ltd. (joined Technetics Group) The Aseptic Group (joined Garlock)
for the pharmaceutical and biopharmaceutical industries
components that has been serving some of the world’s largest pharma companies for over 20 years
components and assemblies used in state-of-the-art semiconductor equipment
technologically advanced microchips for smartphones, autonomous vehicles, high-speed wireless connectivity (5G), artificial intelligence, and other leading-edge applications
The Integration of These Businesses is Progressing According to Plan with Results In Line with Expectations
19
Acquisition increases aftermarket presence in the growing pharmaceutical and biopharmaceutical markets Acquisition increases aftermarket presence in the growing semiconductor wafer production market
Brake Shoe Business Divestiture
(Closed Q3 2019)
brake kits for heavy-duty and medium-duty trucks
with weak differentiation, dilutive margins, and poor cash flow returns on capital
reshaping of heavy-duty truck business to focus on higher margin product lines
TrailerTail Exit
(Q4 2019)
facing aerodynamic devices for improve fuel economy
non-core product line
reshaping of heavy-duty truck business to focus on higher margin product lines
Aeris and AirBatRF Divestitures
(Closed Q1 2020)
inflation systems
pressure monitoring systems
2019
product line
reshaping of heavy-duty truck business to focus on higher margin product lines
Fairbanks Morse Divestiture
(Closed Q1 2020)
diesel engines, primarily for the U.S. Navy
intensive business with lumpy cash flows and customer concentration
that offer highly engineered products and services to niche markets that are based on a core competency of materials science
20
REINVEST IN THE BUSINESS
Q1 2020
balance focused on growth
STRATEGIC ACQUISITIONS
RETURN CASH TO SHAREHOLDERS
February 19; $0.26 dividend declared on April 29
program; additional $5 million repurchased during Q120
2019 CAPITAL ALLOCATION ($M)
(1) Div idend y ield as of 6/8/20
21
$311M $21M $15M $13M $9M
84% ACQUISITIONS 6% SHAREHOLDER DIVIDENDS 4% SHARE REPURCHASES 3% MAINTENANCE CAPEX 3% GROWTH CAPEX
Disciplined Approach to Delivering Shareholder Value
STRATEGIC FIT
✔High addressable market growth, driven by key technology trends ✔Market segment with a high degree of aftermarket exposure ✔High barriers to entry which protect profit margins ✔Fragmented competitive base, providing potential for follow-on acquisitions
FINANCIAL PROFILE
✔Attractive EBITDA margins ✔High cash flow, asset light characteristics ✔EPS accretive
Semiconductor Hygienic and Medical
ENPRO’S M&A CRITERIA ENPRO GROWTH OBJECTIVES
Sustainable Long-Term Growth Drivers Mission-critical Applications High Aftermarket Content Significant Barriers to Entry and Strong Competitive Position
FOCUS AREAS:
22
Combines capabilities that improve productivity, efficiency and innovation in all business units World class standard is always maintained Learning mentality and ownership-based leadership Everyone must play for EnPro Learn from others, contribute to others, ensure commitment and accountability Shared purpose Full release of human possibility Committed to shareholder value creation
23
The EnPro Operating System Enables Margin Expansion and Cash Flow Return on Investment Improvement
24
* Non-GAAP measure; refer to appendix for reconciliation to GAAP
ADJUSTED EBITDA MARGIN* REVENUE GROSS PROFIT MARGIN $1,274 $1,206 $1,185 2018 2019 LTM 3/31/20
($ IN MILLIONS)
14.0% 14.0% 14.8% 2018 2019 LTM 3/31/20 Portfolio Reshaping and Operational Improvements Have Driven Increased Margins 32.8% 33.5% 33.7% 2018 2019 LTM 3/31/20
25
NET DEBT TO EBITDA MULTIPLE FREE CASH FLOW(1) $99 $109 $110 174% 196% 185% 2018 2019 LTM 3/31/20
FREE CASH FLOW AS A % OF ADJUSTED NET INCOME
1.9x 3.0x 0.6x 2018 2019 LTM 3/31/20
(1) Free Cash Flow = Cash Flow from Operations less Capital Expenditures (2) Excludes $78M of tax refund benefit
($ IN MILLIONS)
(2)
2019 Acquisitions of LeanTeq and The Aseptic Group Increased Leverage Ratio 2020 Fairbanks Morse Divestiture De-Levered Business Considerably
27
Portfolio of businesses hold market leading positions as niche providers of precision components, solutions, and services with well-diversified customer bases EnPro Operating System continues to drive margin expansion Shareholder value maximized through a disciplined capital allocation strategy Growth objectives that include sustainable long-term drivers, mission-critical applications, high aftermarket performance, and strong competitive positioning that includes significant barriers to entry
INVESTOR PRESENTATION
Q2 2020
SALES BY GEOGRAPHY SALES BY CHANNEL SALES BY MARKET
systems integration
30 $894 $954 $912 35% 31% 32% 19% 17% 18%
Pro Forma 2017 Consolidated 2018 Consolidated 2019 SALES GROSS MARGIN EBITDA MARGIN 71% NORTH AMERICA 17% EUROPE 9% ASIA 3% ROW 38% HD/MD TRUCK 19% GENERAL INDUSTRIAL 13% SEMICONDUCTOR 12% OIL, GAS & PETROCHEM 6% AEROSPACE 5% POWERGEN 7% OTHER 67% AFTERMARKET 33% OEM
SOFT GASKETS
ISOLATION GASKETS BEARING ISOLATORS SANITARY HOSES SANITARY GASKETS OIL, GAS, & PETROCHEM HEAVY DUTY TRUCKING WHEEL-END PRODUCTS NUCLEAR FOOD & PHARMA SEMICONDUCTOR AEROSPACE METAL SEALS ELECTROSTATIC PEDESTALS CLEANING AND REFURBISHMENT SERVICES
31
32 $302 $324 $298 39% 38% 36% 16% 17% 16%
Pro Forma 2017 Consolidated 2018 Consolidated 2019 SALES GROSS MARGIN EBITDA MARGIN 34% NORTH AMERICA 49% EUROPE 12% ASIA 5% ROW 32% GENERAL INDUSTRIAL 31% OIL, GAS & PETROCHEM 27% AUTOMOTIVE 4% AEROSPACE 6% OTHER 67% OEM 33% AFTERMARKET
SALES BY GEOGRAPHY SALES BY CHANNEL SALES BY MARKET
METAL POLYMER BEARING DRY BEARING FILAMENT WOUND BEARING AEROSPACE GENERAL INDUSTRIAL AUTOMOTIVE
NATURAL GAS PET BOTTLE MANUFACTURING PETROCHEM PACKING CASES PISTON & RIDER RINGS HIGH-FLOW VALVES MONITORING DEVICES TRIBOLOGICAL SOLUTIONS
33
SOLID POLYMER BEARING
EnPro ($ in millions) Revenue ($) Adjusted EBITDA ($) Adjusted EBITDA Margin % Plus: Three Months Ended March 31, 2020 283 41 14.4% Year Ended December 31, 2019 1,206 169 14.0% Less: Three Months Ended March 31, 2019 303 34 11.2% LTM Ended March 31, 2020 1,185 176 14.8% 34 Engineered Products ($ in millions) Revenue ($) Adjusted EBITDA ($) Adjusted EBITDA Margin % Plus: Three Months Ended March 31, 2020 68 8 11.5% Year Ended December 31, 2019 298 47 15.7% Less: Three Months Ended March 31, 2019 80 10 13.1% LTM Ended March 31, 2020 287 44 15.5% Sealing Products ($ in millions) Revenue ($) Adjusted EBITDA ($) Adjusted EBITDA Margin % Plus: Three Months Ended March 31, 2020 216 41 19.1% Year Ended December 31, 2019 912 162 17.7% Less: Three Months Ended March 31, 2019 225 34 15.0% LTM Ended March 31, 2020 903 169 18.7%
35
Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited)
For the Years Ended December 31, 2019 and 2018 (Stated in Millions of Dollars) 2019 2018 Net income (loss) 38.3 $ 19.6 $ Adjustments to arrive at earnings before interest, income taxes, depreciation and amortization (EBITDA): Income from discontinued operations, net of taxes (30.5) (24.3) Interest expense, net 18.2 27.3 Income tax benefit (expense) (3.5) 19.8 Depreciation and amortization expense 68.0 66.1 EBITDA 90.5 108.5 Adjustments to arrive at earnings before interest, income taxes, depreciation, amortization and other selected items (Adjusted EBITDA): Restructuring and impairment costs 35.1 22.1 14.5 13.4 Loss on sale of business 16.3
Acquisition and divestiture expenses 8.9 2.0 Pension expense (income) (non-service cost) 3.3 11.9 Non-controlling interest compensation allocation** 0.5
0.3 2.1 Adjusted EBITDA 169.4 $ 178.1 $ Environmental reserve adjustments and other costs associated with previously disposed businesses Years Ended December 31,
* Adjusted EBITDA as presented also represents the amount defined as "EBITDA" under the indenture governing the Company's 5.75%Senior Notes due 2026. **Non-controlling interest compensation allocation represents compensation expense associated with a portion of the rollover equity from the acquisition of LeanTeq being subject to reduction for certain types of employment terminations of the LeanTeq sellers. This expense is recordedin selling, general, and administration expenses on our Consolidated Statement of Operations and is directly related to the terms of the acquistion ofLeanTeq. This expense will continue to be recognized as compensation expense over the term of the put and call options associated with the acquisition unless certain employment terminations have occured. Supplemental disclosure: For the year ended December 31, 2019, approximately 60% of the adjusted EBITDA as presented above was attributable to EnPro's subsidiaries that do not guarantee the Company's 5.75% Senior Notes due 2026
36
Reconciliation of Net Income Attributable to EnPro Industries, Inc. to Adjusted EBITDA (Unaudited)
For the Three Months Ended March 31, 2020 and 2019 (Stated in Millions of Dollars) 2020 2019 Net income attributable to EnPro Industries, Inc. 218.7 $ 13.1 $ Adjustments to arrive at earnings before interest, income taxes, depreciation and amortization (EBITDA): Income from discontinued operations, net of taxes (208.6) (5.3) Income from redeemable non-controlling interest, net of taxes 0.1
4.0 4.5 Income tax expense 7.7 2.8 Depreciation and amortization expense 17.2 15.6 EBITDA 39.1 30.7 Adjustments to arrive at earnings before interest, income taxes, depreciation, amortization and other selected items (Adjusted EBITDA): Restructuring and impairment costs 1.4 1.3 0.4 0.9 Net gain on sale of businesses (1.1)
0.9 0.5 Pension expense (income) (non-service cost) (0.7) 0.6 Non-controlling interest compensation allocation** 0.5
0.1
40.6 $ 34.0 $ Environmental reserve adjustments and other costs associated with previously disposed businesses
* Adjusted EBITDA as presented also represents the amount defined as "EBITDA" under the indenture governing the Company's 5.75% Senior Notes due 2026. **Non-controlling interest compensation allocation represents compensation expense associated with a portion of the rollover equity from the acquisition of LeanTeq being subject to reduction for certain types of employment terminations of the LeanTeq sellers. This expense is recorded in selling, general, and administration expenses on our Consolidated Statement of Operations and is directly related to the terms of the acquisition of
unless certain employment terminations have occurred. Supplemental disclosure: For the three months ended March 31, 2020, approximately 64% of the adjusted EBITDA as presented above was attributable to EnPro's subsidiaries that do not guarantee the Company's 5.75% Senior Notes due 2026
37
Year Ended December 31, 2019 Sealing Engineered Total Products Products Segments Segment profit 93.8 $ 29.3 $ 123.1 $ Acquisition and divestiture expenses 7.7 0.7 8.4 Non-controlling interest compensation allocation* 0.5
Restructuring and impairment costs 6.6 2.1 8.7 Depreciation and amortization expense 53.1 14.8 67.9 Adjusted segment EBITDA 161.7 $ 46.9 $ 208.6 $ Adjusted segment EBITDA margin 17.7% 15.7% 17.3%
Reconciliation of Segment Profit to Adjusted Segment EBITDA (Unaudited)
For the Quarters ended March 31, 2020 and 2019 and Year Ended December 31, 2019 (Stated in Millions of Dollars)
Three Months Ended March 31, 2020 Sealing Engineered Total Products Products Segments Segment profit 25.7 $ 3.4 $ 29.1 $ Acquisition and divestiture expenses 0.9
Non-controlling interest compensation allocation* 0.5
Restructuring and impairment costs 0.2 1.2 1.4 Depreciation and amortization expense 14.0 3.2 17.2 Earnings before interest, income taxes, depreciation, amortization, and other selected items (adjusted segment EBITDA) 41.3 $ 7.8 $ 49.1 $ Adjusted segment EBITDA margin 19.1% 11.5% 17.4% Three Months Ended March 31, 2019 Sealing Engineered Total Products Products Segments Segment profit 20.8 $ 6.2 $ 27.0 $ Acquisition expenses 0.2 0.3 0.5 Restructuring costs 0.7 0.3 1.0 Depreciation and amortization expense 12.0 3.6 15.6 Adjusted segment EBITDA 33.7 $ 10.4 $ 44.1 $ Adjusted segment EBITDA margin 15.0% 13.1% 14.6%
38
For the Three Months Ended March 31, 2020 and 2019 (Stated in Millions of Dollars, Except Per Share Data) $ Average common shares outstanding, diluted (millions) Per share $ Average common shares outstanding, diluted (millions) Per share Income from continuing operations attributable to EnPro Industries, Inc. 10.1 $ 20.6 0.49 $ 7.8 $ 20.9 0.37 $ Income from redeemable non-controlling interest, net of taxes (0.1)
(7.7) (2.8) Income from continuing operations before income taxes 17.9 10.6 Adjustments: Restructuring and impairment costs 1.4 1.3 Environmental reserve adjustments and other costs associated with previously disposed businesses 0.4 0.9 Net gain on sale of businesses (1.1)
0.9 0.5 Pension expense (income) (non-service cost) (0.7) 0.6 Non-controlling interest compensation allocation*** 0.5
0.1
19.4 13.9 Adjusted income tax expense (6.4) (4.6) Income from redeemable non-controlling interest, net of taxes (0.1)
12.9 $ 20.6 0.62 $ 9.3 $ 20.9 0.45 $ 2020 2019
Reconciliation of Income from Continuing Operations Attributable to EnPro Industries, Inc. to Adjusted Income from Continuing Operations Attributable to EnPro Industries, Inc. and Adjusted Diluted Earnings Per Share (Unaudited)
Management of the Company believes that it would be helpful to the readers of the financial statements to understand the impact of certain selected items on the Company's reported income
** **
39
Earnings Per Share (Unaudited)
(Stated in Millions of Dollars, Except Per Share Data) Years Ended December 31, $ Average common shares outstanding, diluted (millions) Per share $ Average common shares outstanding, diluted (millions) Per share Net income (loss) 38.3 $ 20.8 1.85 $ 19.6 $ 20.9 0.94 $ Income from discontinued operations, net of taxes 30.5 24.3 Income tax expense 3.5 (19.8) Income from continuing operations before income taxes 4.3 15.1 Adjustments: Restructuring and impairment costs 35.1 22.1 Environmental reserve adjustments and other costs associated with previously disposed businesses 14.5 13.4 Loss on sale of business 16.3
Acquisition and divestiture expenses 8.9 2.0 Pension expense (non-service cost) 3.3 11.9 Non-controlling interest compensation allocation*** 0.5
0.3 2.1 Adjusted income from operations before income taxes 83.2 84.7 Adjusted income tax expense (27.5) (28.0) Adjusted net income from continuing operations 55.7 $ 20.8 2.68 $ 56.7 $ 21.1 2.69 $ 2019 2018
Reconciliation of Net Income (Loss) to Adjusted Net Income from Continuing Operations and Adjusted Diluted
** **
40
($ in Millions)
LTM 3/31/20 (=A-B+C) Q12020 (A) Q12019 (B) FY2019 (C) FY2018 Net Cash Provided by (Used in) Operating Activities of Continuing Operations 132.4 0.3 (1.3) 130.8 212.8 Purchases of Property, Plant and Equipment (22.7) (5.2) (4.1) (21.6) (36.1) Free Cash Flow 109.7 (4.9) (5.4) 109.2 176.7 Excluding: 2018 Tax Refund Benefit
Free Cash Flow Excluding 2018 Tax Refund Benefit 109.7 (4.9) (5.4) 109.2 98.7 March 31, 2020 ($M) Q12020 Q12019 Net Cash Provided by (Used in) Operating Activities of Continuing Operations 0.3 (1.3) Purchases of Property, Plant and Equipment (5.2) (4.1) Free Cash Flow (4.9) (5.4) Excluding: Environmental Payments 15.5 0.9 Excluding: Fairbanks Morse Related Receivables 3.2
13.8 (4.5)
41
$ millions December 31, 2018
Credit Facility $117 Senior Notes $345 Capital Lease Obligations $1 A Debt Components $463 B Cash and Equivalents $130 C = (A – B) Net Debt $333 D FY December 31, 2018 Adjusted EBITDA* $178 E = (C / D) Leverage Ratio 1.9x
* Non-GAAP measure; refer to appendix for reconciliation to GAAP
42
Reported December 31, 2019 ($M) Credit Facility $134 Senior Notes(1) $345 Term Loan $149 Capital Lease Obligations $1 A Debt Components $629 B Cash and Equivalents $121 C = (A – B) Net Debt $508 D December 31, 2019 Adjusted EBITDA* $169 E = (C / D) Leverage Ratio 3.0x
(1) Includes impact from unamortized debt issue costs * Non-GAAP measure; refer to appendix for reconciliation to GAAP Note: FY2019 Adjusted EBITDA includes tw o quarters of contribution from The Aseptic Group acquisition and one quarter contribution from LeanTeq acquisition